Global aid cuts to accelerate AMR deaths and economic impact by 2050

Drug-resistant infections could claim millions more lives and severely damage the global economy by 2050, according to new modelling. The study, funded by the UK government and conducted by the Center for Global Development, warns that antimicrobial resistance (AMR) could reduce global GDP by $1.7 trillion annually if no action is taken. Major economies such as the US, UK, and…